Report Type : Therapy Reports
Report Category : Central Nervous System
Report Subcategory : Alzheimer's Disease
Alzheimer's Disease :
Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing
Alzheimer's disease:
Alzheimer's disease (AD) is a progressive neurodegenerative disease that affects memory, thinking, learning, and organizing skills. The disease is caused by a number of factors, including:
- Age
The most significant risk factor for AD is age, with the prevalence of the disease roughly doubling every five years after age 65.
- Genetics
Genetic factors contribute to both early and late-onset AD. For example, Trisomy 21 is a risk factor for early-onset dementia.
- Body weight
Both low and high body weight may increase the risk of AD.
- Other factors
Other factors that may reduce the risk of AD include higher education, estrogen use in women, anti-inflammatory agents, leisure activities, maintaining a healthy diet, and regular aerobic exercise.
The incidence and prevalence of AD vary by region and age group:
- Prevalence
In people aged 60 and older, the prevalence of dementia is estimated to be 3.9% globally, with the highest prevalence in North America (6.4%) and the lowest in Africa (1.6%).
- Incidence
The annual incidence rate of dementia is estimated to be 10.5 per 1,000 people in North America, 8.8 per 1,000 people in Western Europe, 9.2 per 1,000 people in Latin America, and 8.0 per 1,000 people in China and its western-Pacific neighbors.
There's no cure for Alzheimer's, but certain medications and therapies can help manage symptoms temporarily.
Top 50 Key Players:
- Johnson & Johnson
- F. Hoffmann-La Roche Ltd
- Pfizer Inc
- Novartis AG
- Merck & Co Inc
- GlaxoSmithKline Plc
- Sanofi
- AbbVie Inc
- Takeda Pharmaceutical Co Ltd
- Bristol-Myers Squibb Co
- AstraZeneca Plc
- Amgen Inc
- Eli Lilly and Co
- Boehringer Ingelheim International GmbH
- Fujifilm Holdings Corp
- Teva Pharmaceutical Industries Ltd
- Biogen Inc
- Astellas Pharma Inc
- Daiichi Sankyo Co Ltd
- Bausch Health Companies Inc
- Eisai Co Ltd
- Grifols SA
- UCB SA
- Les Laboratoires Servier SAS
- Sumitomo Dainippon Pharma Co Ltd
- CareGroup Inc
- Ono Pharmaceutical Co Ltd
- Octapharma AG
- Zhejiang Hisun Pharmaceutical Co Ltd
- Daewoong Co Ltd
- Chong Kun Dang Pharmaceutical Corp
- Myriad Genetics Inc
- Zhejiang Huahai Pharmaceutical Co Ltd
- Dong-A Socio Holdings Co Ltd
- SRI International
- Dongkook Pharmaceutical Co Ltd
- Supernus Pharmaceuticals Inc
- Vanda Pharmaceuticals Inc
- Denali Therapeutics Inc
- Hyundai Pharma Co Ltd
- Sangamo Therapeutics Inc
- Radius Health Inc
- Suven Life Sciences Ltd
- I'rom Group Co Ltd
- Sosei Heptares
- Adocia SAS
- Arvinas Inc
- GemVax & KAEL Co Ltd
- Icure Pharmaceutical Inc
- Reata Pharmaceuticals Inc
